Funding Alert Vol. 30 No. 4 Alert # 1 - April 2, 2019

Texas Department of State Health Services Funding Information Center Toll free: 1-888-963-7111 ext. 7684 Austin phone: (512) 776-7684 Fax: (512) 776-7683


The Texas Department of State Health Services Funding Alert is published weekly.  If you wish to subscribe to the Funding Information Center Funding Alert and other services, please call (512) 776-7684 or fill out our online subscription form which can be found at: https://dshs.texas.gov/fic/subscribe.aspx.  Information in the Funding Alert is not copyrighted and may be reproduced. The Texas Department of State Health Services Funding Information Center would appreciate credit for the material used and a copy of the reprint. For information on viewing Adobe Acrobat .pdf and other files, see file viewing information.

Disclaimer: External links to other sites are intended to be informational and do not have the endorsement of the Department of State Health Services. These sites may also not be accessible to persons with disabilities. External e-mail links are provided to you as a courtesy. Please be advised that you are not e-mailing the Texas Department of State Health Services (DSHS) and DSHS policies do not apply should you choose to correspond.


Funding News and Grant Tips

Apply for an Outreach Fund Grant
Do you serve a client base that is at least 70 percent African American? If so, you are eligible to apply for a grant from the San Antonio Area African American Community Fund (SAAAACF), an outreach fund of the Area Foundation. 
Deadline to apply is Thursday, April 18, at 1 pm.
Grants will be awarded in the following program areas:
* Arts and culture
* Health
* People in need
* Youth and education
For more information go to http://www.saafdn.org/Nonprofits/Grants/AfricanAmerican.aspx
From San Antonio Area African American Community Fund email, 3/28/19icon

One in 10 Wealthy Donors Plan to Give More
More than a year after the Tax Cuts and Jobs Act of 2017 went into effect, 10 percent of wealthy donors say they plan to give more to charity, while many remain uncertain about how the legislation will affect their giving, a survey by Marts & Lundy finds.
Based on interviews with 105 wealthy donors and an online survey of more than 2,500 donors across income levels, the analysis found that 37 percent of wealthy interviewees and 45 percent of the survey respondents said they didn't know or were unsure of the impact of changes to the tax code. And despite changes that reduce incentives to itemize charitable deductions for some, 10 percent of wealthy donors said they planned to give more and 53 percent said they would give the same, while none said they would give less. 
Among online survey respondents, 10 percent indicated they plan to give more, 39 percent plan to give the same, and 6 percent plan to give less. Those who report giving less than $5,000 annually to charity were more likely to say they plan to give more (14 percent) than those who report giving more than $5,000 annually (11 percent) or wealthy interviewees (10 percent). At the same time, those giving less than $5,000 annually also were less likely than the other two groups to say they plan to give the same amount as before (38 percent) and more likely to say they didn't know or were unsure of the tax law's effect on their giving (44 percent). 
As for why more people whose taxes have been reduced are not digging deeper, Marts & Lundy president and CEO Philippe G. Hills told the Chronicle of Philanthropy that interviews suggest factors such as continuing uncertainty about the impact of the new tax code and the economic outlook, including the future of international trade.
From The Foundation Center's Philanthropy News Digest News email, 3/19/19icon

Gender Pay Gap in Fundraising Persists
The fundraising profession suffers from a gender pay gap, with women fundraisers making about 10 percent less than their male counterparts, a report from the Association of Fundraising Professionals (AFP) finds. 
Released on International Women's Day and based on more than 10,000 survey responses to AFP's Compensation and Benefits Studies between 2014 and 2018, the report, The Impact of Gender on Fundraising Salaries 2014-2018, found that, controlling for other factors, women make 10.5 percent less than their male colleagues. Gender was just one of several factors, however, with organizational size and the individual's position and educational attainment among the factors having the most impact on salary. For example, fundraisers at nonprofits with budgets between $3 million and $9.9 million were paid 18.2 percent more than those at organizations with budgets of less than $1 million, while fundraisers with a doctoral or professional degree earned 15.5 percent more than those without such a degree. 
Supported by DonorPerfect, the report also found that while women comprise a significant majority of the fundraising profession, men were more likely than women to benefit from factors that lead to higher salaries. The survey found, for example, that 42 percent of male respondents worked in an organization with a budget of at least $10 million, compared with a third of women respondents; that nearly 60 percent of men held a higher-level position, compared with 52.5 percent of women; and that 52.3 percent of men had an advanced degree, compared with 42.5 percent of women.
The study also found "negative factors" such as taking time off work to care for family or otherwise interrupting one's career contributed to a 5.7 percent decrease in pay, all other factors being equal, with more than a quarter (25.7 percent) of women respondents reporting that they had experienced one or more negative factors, compared with 15 percent of men. The gap between men and women experiencing specific negative factors was largest for taking time off to care for a child (1.1 percent of men and 11.2 percent of women) and relocating for a spouse (4.2 percent of men and 8.8 percent of women). 
From The Foundation Center's Philanthropy News Digest News email, 3/19/19icon


Public Funding Opportunities

Disparities Elimination through Coordinated Interventions to Prevent and Control Heart and Lung Disease Risk (DECIPHeR) (UG3/UH3 Clinical Trial Optional): RFA-HL-20-003 
SOURCE: National Heart, Lung, and Blood Institute (NHLBI) 
APPLICATION DEADLINE: Letter of Intent: 4/17/19, 9/1/19. Application: 5/17/19, 10/1/19 by 5 pm local time of applicant organization.
$ AVAILABLE: NHLBI intends to fund up to eight awards, corresponding to total costs of up to $7,875,000 in FY 2020 and $10,500,000 per year in FY 2021 through 2026.
ELIGIBILITY: * Public/state/private controlled institutions of higher education.
* Hispanic-serving institutions.
* Historically Black Colleges and Universities (HBCUs).
* Tribally Controlled Colleges and Universities (TCCUs).
* Alaska native and native Hawaiian serving institutions.
* Asian American Native American Pacific Islander Serving Institutions (AANAPISIs).
* Nonprofits with or without 501(c)(3) IRS status (other than institutions of higher education).
* Small businesses.
* For-profit organizations (other than small businesses).
* State governments.
* County governments.
* City or township governments.
* Special district governments.
* Indian/Native American tribal governments (federally recognized and other than federally recognized).
* Eligible agencies of the federal government.
* U.S. territories or possessions.
* Independent school districts.
* Public housing authorities/Indian housing authorities.
* Native American tribal organizations (other than federally recognized tribal governments).
* Faith-based or community-based organizations.
* Regional organizations.
PURPOSE: This Funding Opportunity Announcement (FOA) invites applications for projects that propose to test late-stage (T4) implementation research strategies for optimally and sustainably delivering proven-effective, evidence-based multi-level interventions to reduce or eliminate cardiovascular and/or pulmonary health disparities, and that promote and improve population health in high-burden communities. For the purpose of this FOA, late-stage (T4) implementation research is defined as research to identify strategies to achieve sustainable uptake of proven-effective interventions in routine clinical and public health practice and community-based settings and maximize the positive impact on population health.
CFDA: 93.840, 93.837, 93.838
CONTACT: Please see URL for multiple contacts. For more information see https://grants.nih.gov/grants/guide/rfa-files/RFA-HL-20-003.html
From U.S. Department of Health and Human Services, Office of Minority Health FYI Weekly Health Resources email, 3/27/19icon 
Subject(s) cardiovascular/heart disease, medical research

Disparities Elimination through Coordinated Interventions to Prevent and Control Heart and Lung Disease Risk (DECIPHeR) - Research Coordinating Center (RCC) (U24 Clinical Trial Not Allowed): RFA-HL-20-004 
SOURCE: National Heart, Lung, and Blood Institute (NHLBI) 
APPLICATION DEADLINE: Letter of Intent: 4/17/19, 9/1/19. Application: 5/17/19, 10/1/19 by 5 pm local time of applicant organization.
$ AVAILABLE: NHLBI intends to fund up to one award, corresponding to total costs of up to $750,000 in Fiscal Year 2020, $625,000 total costs in FY2021 to FY2025 and $750,000 in Fiscal year 2026.
ELIGIBILITY: * Public/state/private controlled institutions of higher education.
* Hispanic-serving institutions.
* Historically Black Colleges and Universities (HBCUs).
* Tribally Controlled Colleges and Universities (TCCUs).
* Alaska native and native Hawaiian serving institutions.
* Asian American Native American Pacific Islander Serving Institutions (AANAPISIs).
* Nonprofits with or without 501(c)(3) IRS status (other than institutions of higher education).
* Small businesses.
* For-profit organizations (other than small businesses).
* State governments.
* County governments.
* City or township governments.
* Special district governments.
* Indian/Native American tribal governments (federally recognized and other than federally recognized).
* Eligible agencies of the federal government.
* U.S. territories or possessions.
* Independent school districts.
* Public housing authorities/Indian housing authorities.
* Native American tribal organizations (other than federally recognized tribal governments).
* Faith-based or community-based organizations.
* Regional organizations.
PURPOSE: The National Heart, Lung, and Blood Institute invites applications for a Research Coordinating Center (RCC) to support projects from RFA-HL-20-003 Disparities Elimination through Coordinated Interventions to Prevent and Control Heart and Lung Disease Risk (DECIPHeR), which will test late-stage (T4) implementation strategies for optimally and sustainably delivering proven-effective, evidence-based, multi-level interventions to reduce or eliminate cardiovascular and/or pulmonary health disparities, and promote and improve population health in high-burden communities. 
CFDA: 93.840, 93.837, 93.838
CONTACT: Please see URL for multiple contacts. For more information see https://grants.nih.gov/grants/guide/rfa-files/RFA-HL-20-004.html
From U.S. Department of Health and Human Services, Office of Minority Health FYI Weekly Health Resources email, 3/27/19icon 
Subject(s) cardiovascular/heart disease, medical research

Newborn Screening State Evaluation Program: HRSA-19-097
SOURCE: Health Resources and Services Administration (HRSA)
APPLICATION DEADLINE: 5/6/19.
$ AVAILABLE: $2,250,000 for 15 awards.
ELIGIBILITY: Eligible applicants include states or political subdivisions of a state or a consortium of two or more states or political subdivisions of states.
PURPOSE: The purpose of this program is to collect data in order to improve evaluation of state newborn screening programs and to build state-level capacity to assess and report on the effectiveness of screening, including timeliness, follow up, counseling, and health care services, in reducing the morbidity and mortality caused by heritable disorders in newborns and children. 
CFDA: 93.110
CONTACT: Andrea M. Matthews, (301) 945-3062, email: amatthews@hrsa.gov. For more information see https://www.grants.gov/web/grants/view-opportunity.html?oppId=313499&utm_campaign=fyi_newsletter&utm_medium=email&utm_source=govdelivery
From U.S. Department of Health and Human Services, Office of Minority Health FYI Weekly Health Resources email, 3/27/19icon 
Subject(s) medical research

Rural Communities Opioid Response Program-Implementation: HRSA-19-082
SOURCE: Health Resources and Services Administration (HRSA)
APPLICATION DEADLINE: 5/6/19.
$ AVAILABLE: $75 million for 75 awards.
ELIGIBILITY: Eligible applicants include all domestic public or private, nonprofit or for-profit entities, including faith-based and community-based organizations, tribes, and tribal organizations and should serve rural communities at the highest risk for SUD. 
PURPOSE: The Rural Communities Opioid Response Program (RCORP) is a multi-year opioid-focused initiative by the Health Resources and Services Administration (HRSA) aimed at reducing the morbidity and mortality of substance use disorder (SUD), including opioid use disorder (OUD), in rural communities at the highest risk for SUD. 
CFDA: 93.912
CONTACT: Allison Hutchings, (301) 945-9819, email: ruralopioidresponse@hrsa.gov. For more information see https://www.grants.gov/web/grants/view-opportunity.html?oppId=311848&utm_campaign=fyi_newsletter&utm_medium=email&utm_source=govdelivery
From U.S. Department of Health and Human Services, Office of Minority Health FYI Weekly Health Resources email, 3/27/19icon 
Subject(s) opioid overdose epidemic, rural health, substance abuse research


Private Funding Opportunities

American Psychological Foundation Accepting Applications for Innovative Anxiety Disorders Research
SOURCE: American Psychological Foundation (APF)
APPLICATION DEADLINE: 9/18/19.
$ AVAILABLE: A single grant of up to $7,500. 
ELIGIBILITY: To be eligible for the grant, applicants must be a graduate student or early-career researcher (no more than ten years postdoctoral) and be affiliated with a nonprofit charitable, educational, or scientific institution or a governmental entity operating exclusively for charitable and educational purposes.
PURPOSE: The American Psychological Foundation is accepting applications for its David H. And Beverly A. Barlow Grant.
Through the program, a single grant of up to $7,500 will support novel basic and clinical research on anxiety and anxiety-related disorders conducted by a graduate student or early-career researcher.
CONTACT: Please see URL for contact information. For more information see https://www.apa.org/apf/funding/barlow?tab=3
From The Foundation Center's Philanthropy News Digest web site, accessed 3/28/19icon
Subject(s) medical research

Hillman Foundation Invites Applications for Serious Illness and End of Life Emergent Innovation Program
SOURCE: Rita and Alex Hillman Foundation 
APPLICATION DEADLINE: Letters of Intent are due 4/29/19. Upon review, selected applicants will be invited to submit a full proposal by 7/22/19.
$ AVAILABLE: Five grants of $50,000. 
ELIGIBILITY: Eligible candidates include organizations that are tax exempt under section 501(c)(3) of the Internal Revenue Code and not classified as private foundations; international organizations that are equivalent to a 501(c)(3) organization with a project focuses on the U.S.; government entities; and faith-based organizations that welcome and serve all members of the community regardless of religious belief.
PURPOSE: The Rita and Alex Hillman Foundation supports nurse-led healthcare innovation and research, with the goal of improving patient care in hospitals, clinics, homes, and communities. Nurses operate at the junction of public policy, medical science, systems-based healthcare delivery, and one-on-one patient care. Drawing on its knowledge of this unique and important role, the foundation believes it has valuable insights with respect to relevant modes of research and alternative models that can lead to more equitable, patient-centered health care.
To that end, the foundation is accepting applications for its Hillman Emergent Innovation Serious Illness and End of Life Emergent Innovation program. Through the program, up to five grants of $50,000 will be awarded in support of pre-evidence or untested innovations that challenge traditional approaches to serious illness and end-of-life care and lead to bold, nursing-driven interventions targeting the unmet needs of vulnerable populations, including the economically disadvantaged, racial and ethnic minorities, LGBTQ people, the homeless, rural populations, and others.
Priority will be given to proposals that include one or more of the following: engagement of patients, families, caregivers and/or community organizations; inter-professional or multidisciplinary collaboration; institutional and community partnerships; provision of care in non-hospital settings; and measurable goals and outcomes.
The foundation believes that transformative ideas are as likely to come from small community care settings as they are from major academic research centers and thus supports innovations from a broad range of institutions, care settings, and practitioners (including postdocs, adjunct faculty, and interdisciplinary faculty).
CONTACT: Please see URL for contact information. For more information see http://www.rahf.org/documents/website/2019_HSEI_RFP_20190315.pdf
From The Foundation Center's Philanthropy News Digest web site, accessed 3/28/19icon
Subject(s) health care services, nursing

Michael J. Fox Foundation Issues RFA for Assay Development and Validation for Alpha-Synuclein
SOURCE: Michael J. Fox Foundation (MJFF)
APPLICATION DEADLINE: Pre-proposals are due 4/19/19. Upon review, selected candidates will be asked to submit a full proposal by 7/19/19.
$ AVAILABLE: Grants of up to $200,000. 
ELIGIBILITY: Eligible applicants include researchers and clinicians in U.S. and non-U.S. biotechnology/pharmaceutical companies or other privately or publicly held for-profit entities as well as those affiliated with U.S. and non-U.S. public and private nonprofit entities such as universities, colleges, hospitals, laboratories, units of state and local government, and eligible agencies of the federal government. Postdoctoral fellows are eligible to apply as co-investigators with the designation of an administrative primary investigator who directs the laboratory in which the fellow will conduct research.
PURPOSE: The Assay Development and Validation for Quantifying Oligomeric Alpha-Synuclein program at the Michael J. Fox Foundation is dedicated to advancing the development, optimization, and validation of assays to quantify oligomeric alpha-synuclein in human body fluids.
Multiple groups using a variety of analytical techniques have reported the presence of different species of aSyn in biofluids such as blood, cerebrospinal fluid (CSF), saliva, and tears. Results suggest that aSyn levels may be different in Parkinson’s disease compared to healthy controls. Thus, aSyn quantification in accessible body fluids may serve as a biomarker of disease diagnosis, target engagement, pharmacodynamic response, or patient stratification. At the same time, analysis of total aSyn in CSF collected in the Parkinson's Progression Markers Initiative (PPMI) study did not change significantly over the course of a year, indicating that total aSyn may not be a progression marker of PD. One of the hallmarks of PD is aSyn aggregation, and therefore oligomeric aSyn may represent a more pathologically relevant disease species to serve as a biomarker.
Through the program, grants of up to $200,000 over twelve months will be awarded in support of research focused on the development, optimization, and validation of assays using any available technology/platform, including non-ELISA-based approaches. Awardees under the program will be integrated into MJFF's ongoing Investigating Synuclein Consortium, which is composed of key opinion leaders in the aSyn field. 
CONTACT: Please see URL for contact information. For more information see https://www.michaeljfox.org/
From The Foundation Center's Philanthropy News Digest web site, accessed 3/28/19icon
Subject(s) medical research

Michael J. Fox Foundation Issues RFA for Imaging Biomarkers to Track Disease Progression, Therapeutic Efficacy
SOURCE: Michael J. Fox Foundation (MJFF)
APPLICATION DEADLINE: Pre-proposals are due 4/19/19. Upon review, selected candidates will be asked to submit a full proposal by 7/19/19.
$ AVAILABLE: Grants of up to $750,000. 
ELIGIBILITY: Eligible candidates include researchers and clinicians working for U.S. and non-U.S. biotechnology/pharmaceutical companies or other privately or publicly held for-profit entities; U.S. and non-U.S. public and private nonprofit entities such as universities, colleges, hospitals, and laboratories; and units of state and local government and eligible agencies of the federal government.
PURPOSE: The Imaging Biomarkers to Track Disease Progression and Therapeutic Efficacy program at the Michael J. Fox Foundation is dedicated to developing imaging markers for use in disease-modifying clinical trials.
Imaging is a powerful tool that can be used to visualize the structure and function of the brain in living subjects. While a variety of imaging techniques — including positron emission tomography (PET), single photon emission computed tomography (SPECT), and magnetic resonance imaging (MRI) — are available, none of them has been demonstrated to be a sensitive, specific, and reliable biomarker for the presence and progression of Parkinson’s disease. Thus, an imaging biomarker would be extremely useful for drug development as an outcome measure in clinical trials. As imaging the key pathology of PD would be the most direct (and hopefully most sensitive) means of measuring the progression of disease and therapeutics that alter disease progression, the foundation has prioritized alpha-synuclein imaging as the most likely imaging approach to have an impact on therapeutic development.
To that end, MJFF is inviting proposals for research with the potential to develop robust and precise imaging markers and modalities that could be used to track Parkinson’s disease progression and therapeutic efficacy in disease-modifying trials. Through the program, grants of up to $750,000 over one to three years will be awarded.
High-priority targets identified by the foundation include alpha-synuclein and novel markers of neuroinflammation, as well as other promising therapeutic targets. Projects should be aimed at developing novel imaging biomarkers as opposed to prospective studies to collect data using existing technologies. Examples of projects that are appropriate for this funding opportunity include novel PET or SPECT tracer development, early validation of newly developed tracers, and development and validation of novel MRI techniques. Imaging modalities can include PET, SPECT and MRI. Prospective data collection is appropriate only if the imaging technique is novel or if a novel tracer is being tested.
CONTACT: Please see URL for contact information. For more information see https://www.michaeljfox.org/research/grant-detail.php?id=41
From The Foundation Center's Philanthropy News Digest web site, accessed 3/28/19icon
Subject(s) medical research

Michael J. Fox Foundation Issues RFA for Research of Biology of Astrocytes in Parkinson’s Disease
SOURCE: Michael J. Fox Foundation (MJFF)
APPLICATION DEADLINE: Pre-proposals are due 4/19/19. Upon review, selected candidates will be asked to submit a full proposal by 7/19/19.
$ AVAILABLE: Grants of up to $150,000. 
ELIGIBILITY: Eligible applicants include researchers and clinicians in U.S. and non-U.S. biotechnology/pharmaceutical companies or other privately or publicly held for-profit entities and U.S. and non-U.S. public and private nonprofit entities such as universities, colleges, hospitals, laboratories, units of state and local governments, and eligible agencies of the federal government. Postdoctoral fellows are eligible to apply as co-investigators with the designation of an administrative primary investigator who directs the laboratory in which the fellow will conduct research.
PURPOSE: The Biology of Astrocytes in Parkinson’s Disease program at the Michael J. Fox Foundation for Parkinson’s Research exists to further the understanding of astrocyte biology in Parkinson’s and to rationalize the pursuit of astrocyte-specific targets and/or pathways for the treatment of the disease.
Astrocytes play a role in neurotransmitter regulation and trophic and metabolic support of neurons and help modulate vascular functioning. Current research on inflammation in the central nervous system is exploring the role of astrocytes beyond simple “reactive gliosis” and their interaction with microglia. There is emerging evidence that these cells could be participating in a novel drainage system in the brain. Recent evidence from Alzheimer’s disease research has hinted that astrocytes could be propagators, and potentially initiators, of neuroinflammation. Postmortem examinations of brains from Parkinson’s disease patients reveal “reactive” astrocytes and astrocytes that contain alpha-synuclein-positive inclusions.
Through the Biology of Astrocytes program, MJFF will award grants of up to $150,000 over twelve to eighteen months to researchers addressing current gaps in our knowledge of the role of astrocytes in Parkinson’s disease pathology and the potential for astrocyte-focused therapeutics.
MJFF prioritizes proposals that are dedicated to the role of astrocytes in initiating and/or propagating Parkinson’s disease pathology, including alpha-synuclein spread, dopaminergic neuron death, inflammation, and senescence; the consequences of dysfunction and/or mutations of common PD targets in astrocytes, including alpha-synuclein, LRRK2, GBA, Parkin, PINK1; and the manipulation of astrocyte activity and/or astrocyte-specific pathways to assess the disease modifying or symptomatic therapeutic potential of targeted astrocyte therapies. Preference will be given to proposals using Parkinson’s disease models with high construct validity to human PD, including patient-derived material (such as iPSCs or cerebral organoids) and/or well characterized animal models and primary cells. Examination of human brain samples to answer specific hypotheses also will be acceptable.
CONTACT: Please see URL for contact information. For more information see https://www.michaeljfox.org/research/grant-detail.php?id=42
From The Foundation Center's Philanthropy News Digest web site, accessed 3/28/19icon
Subject(s) medical research

Prostate Cancer Foundation Accepting Application for 2019 Challenge Awards
SOURCE: Prostate Cancer Foundation 
APPLICATION DEADLINE: 4/22/19.
$ AVAILABLE: Awards of up to $1 million. 
ELIGIBILITY: To be eligible, researchers must be affiliated with a nonprofit academic research center. Young investigator team members may hold the title of postdoctoral fellow, instructor, research associate, or assistant professor (or equivalent), and should be within six years of the completion of a professional degree (MD, DO, PhD, MD-PhD, DSc, ScD, DDM, DDS, DMD, MBBS, or equivalent) or subsequent mentored academic or clinical training program. In addition, s/he must not receive more than $200,000 in direct research funding from all sources (including institutional funds) during the two-year term of the award. 
PURPOSE: The Prostate Cancer Foundation has announced a request for applications for its PCF Challenge Awards.
Through the program, awards of up to $1 million over two years will be made to teams of at least three investigators conducting large-scale research projects focused on metastatic, lethal prostate cancer. Teams must be based at a nonprofit academic research center, include one young investigator (as defined by the foundation), and be comprised of investigators at either a single institution or at several institutions.
The foundation seeks research proposals dedicated to the following priority areas: immunotherapy for the treatment of metastatic, lethal prostate cancer; targeted radionuclide therapy for advanced prostate cancer; new systemic precision treatments for metastatic, lethal prostate cancer (including those targeting the currently “undruggable”); first-in-field research on new targets for systemic treatment of metastatic, lethal prostate cancer; mechanisms of resistance to current and investigational drugs targeting the androgen receptor and androgen axis, immune system, chemotherapy, and other targeted agents; correlative research around either clinical trials of novel agents or strategies or standard of care; the development or validation of biomarkers that can guide therapy in patients or further understanding of the mechanisms by which therapies work; tumor microenvironment signaling related to cancer progression (including the immune component); and new data science technologies for analysis of genomic information to advance precision medicine.
Currently unfunded high-risk projects are encouraged, as are applications from investigators with a VA appointment.
CONTACT: Please see URL for contact information. For more information see https://www.pcf.org/wp-content/uploads/2019/01/2019_Challenge_Awards_RFA.pdf
From The Foundation Center's Philanthropy News Digest web site, accessed 3/28/19icon
Subject(s) cancer research

Robert Wood Johnson Foundation Invites ‘Pioneering Ideas’ Proposals
SOURCE: Robert Wood Johnson Foundation (RWJF)
APPLICATION DEADLINE: 10/15/19.
$ AVAILABLE: Grants awarded through this funding opportunity generally will range between $150,000 and $350,000 over one to three years.
ELIGIBILITY: The program accepts various types of projects, including research, pilots or demonstration projects; idea sourcing; network or coalition building; and more.
PURPOSE: The aim of the Robert Wood Johnson Foundation ‘s Pioneering Ideas Brief Proposal funding opportunity is to put health first as it looks into the future and works to develop clarity as to the trends, opportunities, and ideas that can enable everyone in the America to live the healthiest life possible.
To that end, the program is accepting applications for projects that seek to explore how cutting-edge ideas and emerging trends could help or hinder progress toward a Culture of Health — defined by RWJF as placing well-being at the center of every aspect of individuals' lives and ensuring that everyone has access to the care they need as well as a fair and just opportunity to make healthier choices.
CONTACT: Please see URL for contact information. For more information see https://www.rwjf.org/en/how-we-work/submit-a-proposal.html
From The Foundation Center's Philanthropy News Digest web site, accessed 3/28/19icon
Subject(s) health policy research

Sigma Foundation for Nursing Accepting Applications for STTI/Chamberlain College of Nursing Education Research Grants
SOURCE: Sigma Foundation for Nursing 
APPLICATION DEADLINE: 5/1/19.
$ AVAILABLE: Two grants of up to $10,000 each.
ELIGIBILITY: To be eligible, principal investigator(s) must be a member in good standing of Sigma, be a registered nurse (or country equivalent) with a current license, and have at least a master’s in nursing (or country equivalent).
PURPOSE: Through its research funding, the Sigma Foundation for Nursing seeks to provide resources that help bridge the gap between research and clinical practice.
To that end, the foundation is accepting applications for the Sigma Theta Tau International/Chamberlain College of Nursing Education Research Grants program. Through the program, two grants of up to $10,000 each will be awarded to researchers focused on excellence and innovation in nursing education. The program supports a variety of issues in nursing academia, including those related to nursing faculty and students, teaching and learning, clinical and didactic education, in person and online classroom settings, and simulation.
Applicants must be ready to implement their research project upon receipt of funding, hold a proof of Institutional Review Board approval (or country equivalent), and complete their project within 12 months of funding.
CONTACT: Please see URL for contact information. For more information see https://www.sigmanursing.org/advance-elevate/research/research-grants/chamberlain-college-of-nursing-education-research-grants
From The Foundation Center's Philanthropy News Digest web site, accessed 3/28/19icon
Subject(s) medical research, nursing

Syringe Access Fund Invites Applications from Sterile Syringe Programs
SOURCE: AIDS United 
APPLICATION DEADLINE: 6/14/19.
$ AVAILABLE: Grants of up to $5,000. 
ELIGIBILITY: Community-based organizations and AIDS service organizations, as well as faith-based and human rights groups, clinical or medical providers, and legal aid organizations are eligible to apply. Applicants must be tax-exempt under section 501(c)(3) of the Internal Revenue Code (or have a tax-exempt fiscal sponsor). Projects may be located in any of the fifty states, the District of Columbia, Native American reservations/tribal land, the U.S. Virgin Islands, Puerto Rico, or any U.S. territory.
PURPOSE: A program of AIDS United established, the Syringe Access Fund is a national grantmaking initiative that supports service providers and policy initiatives aimed at reducing the spread of HIV, hepatitis C, and other blood-borne pathogens among people who inject drugs and their sexual partners through expanded access to sterile syringes.
The fund is currently offering off-cycle grants of up to $5,000 over six months in support of startup programs offering sterile syringe services and emerging policy initiatives. Programs that include drug users in the design, delivery, and evaluation of services as well as programs that are peer- and volunteer-run will receive priority consideration. Strategic partnerships are encouraged.
CONTACT: Please see URL for contact information. For more information see https://www.aidsunited.org/data/files/Site_18/SAF/2019-SAF-Off-Cycle-RFP.pdf
From The Foundation Center's Philanthropy News Digest web site, accessed 3/28/19icon
Subject(s) HIV/AIDS education/prevention


Events

Essentials of Grant Writing -- In Person or Webinar 
SPONSOR: Texas Department of State Health Services, Funding Information Center (FIC)
WHEN: April 8, 8:30 to 11:30 am.
WHERE: In Person -- DSHS Main Campus, Moreton Building, Room M-100, 1100 West 49th Street, (Austin, TX).
Webinar -- Your home or office.
DESCRIPTION: This workshop provides you with an overview of the grant writing process including: identifying funding, developing a project plan, budget, needs statement, goals, objectives, and evaluation plan. You will learn about the process of grant writing from reading the RFP to submitting the proposal as well as helpful tips on grantmaking from the funder’s perspective. Whether you are new to grant writing or looking for a refresher course, this workshop will give you more confidence in your ability to apply for your next (or first) grant. 
COST: Free, but registration is required for either the in-person or webinar. 
Registration for the Essentials of Grant Writing is closed. To register to attend remotely via webinar go to https://attendee.gotowebinar.com/register/5629510926747383297. No registration limits.
CONTACT: Doug Jumper, (512) 776-7684, email: doug.jumper@dshs.texas.gov.
From DSHS Funding Information Center, 3/28/19icon

Webinar - Quest for Grants Training Series: Grant Writing Best Practices
SPONSOR: Harris County Department of Education, Center for Grants Development 
WHEN: April 24, 1:30 to 3 pm.
WHERE: Webinar.
DESCRIPTION: Please see URL for description.
COST: In Harris County: $25. Outside Harris County: $45. For more information and registration go to https://hcde-texas.org/workshops/
CONTACT: Jessica Vaquera, (713) 694-6300, email: jvaquera@hcde-texas.org.
From Harris County Department of Education email, 3/26/19icon

Webinar - Quest for Grants Training Series: Team Approach to Proposal Writing
SPONSOR: Harris County Department of Education, Center for Grants Development 
WHEN: May 22, 1:30 to 3 pm.
WHERE: Webinar.
DESCRIPTION: Team Approach to Proposal Writing is a one-and-a-half-hour session of a four-part webinar series. 
The session covers: 
* Creating an effective proposal writing team. 
* Steps taken towards the planning, preparation, and submission of grant proposals.
* Proven strategies used in the development of proposals. 
* Tools and techniques to organize your grant proposal files.
* Ways to promote team success.
COST: In Harris County: $25. Outside Harris County: $45. For more information and registration go to https://hcde-texas.org/workshops/
CONTACT: Jessica Vaquera, (713) 694-6300, email: jvaquera@hcde-texas.org.
From Harris County Department of Education email, 3/26/19icon 

Webinar - Quest for Grants Training Series: The Grant Budget: It's Not Just About the Math
SPONSOR: Harris County Department of Education, Center for Grants Development 
WHEN: June 20, 1:30 to 3 pm.
WHERE: Webinar.
DESCRIPTION: Please see URL for description.
COST: In Harris County: $25. Outside Harris County: $45. For more information and registration go to https://hcde-texas.org/workshops/
CONTACT: Jessica Vaquera, (713) 694-6300, email: jvaquera@hcde-texas.org.
From Harris County Department of Education email, 3/26/19icon 


Awards in Texas

The Texas Health and Human Services Commission (HHSC) has secured $84 million to help fund physician resident positions at public teaching hospitals in Texas.
These dollars, through graduate medical education payments from Medicaid, are designated for non-state, government-owned and -operated teaching hospitals and will help expand the state’s ability to attract and retain doctors.
HHSC also is pursuing similar funding for privately owned and operated teaching hospitals. Texas will submit its request for private hospital funding to the Centers for Medicare and Medicaid Services this spring, with an anticipated April 1 effective date.
With the expanded funding, Texas expects to see an increase in the number of residency positions for medical school graduates because hospitals will be better equipped to cover training expenses for interns and residents. Increasing the number of available residency positions in Texas strengthens the state’s ability to retain doctors.
Hospitals able to receive this new funding include:
* Harris County Hospital District, Houston
* Hunt Regional Medical Center, Greenville
* John Peter Smith Hospital, Fort Worth
* Medical Center Hospital, Odessa
* Midland Memorial Hospital, Midland
* Parkland Memorial Hospital, Dallas
* University Health System, San Antonio
* University Medical Center of El Paso
* University Medical Center, Lubbock

From Texas Health and Human Services Commission email, 3/26/19icon


returnReturn to Alert

Last updated April 5, 2019